跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZOMIG FLAS 2,5 mg COMPRIMIDOS BUCODISPERSABLES - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ZOMIG FLAS 2,5 mg COMPRIMIDOS BUCODISPERSABLES
Approved
STANDARD
ZOMIG FLAS 2,5 mg COMPRIMIDOS BUCODISPERSABLES
Laboratoires Grunenthal
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 5, 2021
Approval ID
b71f227e47540f82
Company
Laboratoires Grunenthal
Type
Standard
Approval Details
Approval Id
b71f227e47540f82
Drug Cima Aemps Name
ZOMIG FLAS 2,5 mg COMPRIMIDOS BUCODISPERSABLES
Register Number
34009_353_366_5_1
Holder Company Name
Laboratoires Grunenthal
Marketing Company Name
Difarmed S.L.U.
Authorization Date
2021-05-05
Dosage Form
COMPRIMIDO BUCODISPERSABLE
Dose
2,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratoires Grunenthal
Active Ingredients
ZOLMITRIPTAN
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 5, 2021
Approval ID
b71f227e47540f82
Type
Standard
Back to CIMA-AEMPS Approvals
